Medtronic plc (LON:0Y6X)

Verve Therapeutics Statistics

Total Valuation

Medtronic has a market cap or net worth of GBP 86.42 billion. The enterprise value is 102.18 billion.

Market Cap	86.42B
Enterprise Value	102.18B

Important Dates

The next estimated earnings date is Tuesday, August 19, 2025.

Earnings Date	Aug 19, 2025
Ex-Dividend Date	Jun 27, 2025

Share Statistics

Current Share Class	1.28B
Shares Outstanding	n/a
Shares Change (YoY)	-3.03%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.28B

Valuation Ratios

The trailing PE ratio is 24.67 and the forward PE ratio is 16.05.

PE Ratio	24.67
Forward PE	16.05
PS Ratio	3.43
PB Ratio	2.38
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.38, with an EV/FCF ratio of 26.23.

EV / Earnings	29.17
EV / Sales	4.04
EV / EBITDA	14.38
EV / EBIT	21.14
EV / FCF	26.23

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.61.

Current Ratio	1.85
Quick Ratio	1.20
Debt / Equity	0.61
Debt / EBITDA	3.15
Debt / FCF	5.71
Interest Coverage	8.78

Financial Efficiency

Return on equity (ROE) is 9.51% and return on invested capital (ROIC) is 5.19%.

Return on Equity (ROE)	9.51%
Return on Assets (ROA)	4.41%
Return on Invested Capital (ROIC)	5.19%
Return on Capital Employed (ROCE)	8.13%
Revenue Per Employee	265,228
Profits Per Employee	36,870
Employee Count	95,000
Asset Turnover	0.37
Inventory Turnover	2.17

Taxes

In the past 12 months, Medtronic has paid 703.23 million in taxes.

Income Tax	703.23M
Effective Tax Rate	16.63%

Stock Price Statistics

The stock price has increased by +10.52% in the last 52 weeks. The beta is 0.82, so Medtronic's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	+10.52%
50-Day Moving Average	87.57
200-Day Moving Average	87.27
Relative Strength Index (RSI)	46.28
Average Volume (20 Days)	2,600

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.68

Income Statement

In the last 12 months, Medtronic had revenue of GBP 25.20 billion and earned 3.50 billion in profits. Earnings per share was 2.71.

Revenue	25.20B
Gross Profit	16.48B
Operating Income	4.81B
Pretax Income	4.23B
Net Income	3.50B
EBITDA	6.85B
EBIT	4.81B
Earnings Per Share (EPS)	2.71

Balance Sheet

The company has 6.74 billion in cash and 22.26 billion in debt, giving a net cash position of -15.51 billion.

Cash & Cash Equivalents	6.74B
Total Debt	22.26B
Net Cash	-15.51B
Net Cash Per Share	n/a
Equity (Book Value)	36.26B
Book Value Per Share	28.15
Working Capital	8.22B

Cash Flow

In the last 12 months, operating cash flow was 5.29 billion and capital expenditures -1.40 billion, giving a free cash flow of 3.90 billion.

Operating Cash Flow	5.29B
Capital Expenditures	-1.40B
Free Cash Flow	3.90B
FCF Per Share	n/a

Margins

Gross margin is 65.39%, with operating and profit margins of 19.09% and 13.90%.

Gross Margin	65.39%
Operating Margin	19.09%
Pretax Margin	16.78%
Profit Margin	13.90%
EBITDA Margin	27.17%
EBIT Margin	19.09%
FCF Margin	15.46%

Dividends & Yields

This stock pays an annual dividend of 2.14, which amounts to a dividend yield of 2.40%.

Dividend Per Share	2.14
Dividend Yield	2.40%
Dividend Growth (YoY)	-2.90%
Years of Dividend Growth	n/a
Payout Ratio	76.98%
Buyback Yield	3.03%
Shareholder Yield	5.43%
Earnings Yield	4.05%
FCF Yield	4.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medtronic has an Altman Z-Score of 2.74 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.74
Piotroski F-Score	5